NANOGEN ISSUED PATENT RELATING TO BIOLOGICAL SCREENING DEVICE

Nanogen recently announced it was issued Patent No. 6,942,778, "Microstructure Apparatus and Method for Separating Differently Charged Molecules Using an Applied Electric Field" by the U.S. Patent and Trademark Office. The '778 patent relates to a biological screening device used to monitor the activity of kinase, protease or phosphatase enzymes on peptide substrates. The device may be used to monitor a change in net charge of a target molecule as a result of enzyme activity. The technology described in Nanogen's 132nd patent also allows for simpler, faster and safer molecular analyses using fluorescent labeling.

News-Medical.net (http://www.news-medical.net/?id=13334)